CD40 SIGNALING THROUGH TNF RECEPTOR ASSOCIATED FACTORS

通过 TNF 受体相关因子进行 CD40 信号传导

基本信息

  • 批准号:
    6628893
  • 负责人:
  • 金额:
    $ 26.17万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-02-01 至 2005-01-31
  • 项目状态:
    已结题

项目摘要

Tumor necrosis factor (TNF) has been considered as an anti-cancer agent since its discovery two decades ago. Members of the TNF receptor (TNFR) superfamily can send both survival and death signals to cells, and play important roles in a wide range of biological effects that include acute phase responses and lymphocyte activation. CD40, as a member of this receptor family, activates multiple signaling pathways, induces expression of dozens of genes, and is essential for many important events in T-cell-dependent humoral responses. Our goal is to find connections that can link the CD40 receptor to multiple signal transduction pathways, and that link each signaling pathway to its downstream effector genes and to the CD40-mediated biological functions. The recent discovery of several early signaling mediators, including the TNF receptor-associated factor (TRAF) family proteins, the TRAF- associated NF-kappaB activator (TANK) and the NF-kappaB-inducing kinase (NIK), has provided an opportunity to dissect multiple CD40-mediated signal transduction pathways. This proposal will focus on the early events of CD40 receptor-initiated signaling. First, we will determine the specificities of multiple TRAF proteins for receiving signals from CD40 and for sending out downstream signals to activate both the NF-kappaB and stress-activating protein kinase (SAPK) signal transduction pathways. Second, we will determine the molecular mechanisms of TRAF and TANK cooperation. We will also test the possible role of TANK as a switching molecule in controlling the threshold of CD40-induced NF-KB and SAPK activation. Our work will: 1) provide new insights into the molecular mechanisms by which a single receptor interacting with its ligand can generate multiple signal transduction pathways and control multiple biological events; and 2) identify new therapeutic targets in the multiple CD40 and TNF signaling pathways for treatment of cancers and immune diseases.
肿瘤坏死因子(Tumor necrosis factor, TNF)一直被认为是一种抗癌药物

项目成果

期刊论文数量(13)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Noncanonical NF-kappaB activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK.
  • DOI:
    10.1038/ni.1676
  • 发表时间:
    2008-12
  • 期刊:
  • 影响因子:
    30.5
  • 作者:
    Zarnegar, Brian J.;Wang, Yaya;Mahoney, Douglas J.;Dempsey, Paul W.;Cheung, Herman H.;He, Jeannie;Shiba, Travis;Yang, Xiaolu;Yeh, Wen-chen;Mak, Tak W.;Korneluk, Robert G.;Cheng, Genhong
  • 通讯作者:
    Cheng, Genhong
Rescue of TRAF3-null mice by p100 NF-kappa B deficiency.
p100 nf-kappa b缺陷营救traf3-null小鼠。
TANK potentiates tumor necrosis factor receptor-associated factor-mediated c-Jun N-terminal kinase/stress-activated protein kinase activation through the germinal center kinase pathway.
TANK 通过生发中心激酶途径增强肿瘤坏死因子受体相关因子介导的 c-Jun N 末端激酶/应激激活蛋白激酶的激活。
  • DOI:
    10.1128/mcb.19.10.6665
  • 发表时间:
    1999
  • 期刊:
  • 影响因子:
    5.3
  • 作者:
    Chin,AI;Shu,J;ShanShi,C;Yao,Z;Kehrl,JH;Cheng,G
  • 通讯作者:
    Cheng,G
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GENHONG CHENG其他文献

GENHONG CHENG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GENHONG CHENG', 18)}}的其他基金

Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10222540
  • 财政年份:
    2020
  • 资助金额:
    $ 26.17万
  • 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10174522
  • 财政年份:
    2020
  • 资助金额:
    $ 26.17万
  • 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10461773
  • 财政年份:
    2020
  • 资助金额:
    $ 26.17万
  • 项目类别:
Genetic evolution, pathogenesis and immune responses in mother to child transmission of ZIKV
ZIKV 母婴传播的遗传进化、发病机制和免疫反应
  • 批准号:
    9925059
  • 财政年份:
    2018
  • 资助金额:
    $ 26.17万
  • 项目类别:
Genetic evolution, pathogenesis and immune responses in mother to child transmission of ZIKV
ZIKV 母婴传播的遗传进化、发病机制和免疫反应
  • 批准号:
    10388193
  • 财政年份:
    2018
  • 资助金额:
    $ 26.17万
  • 项目类别:
IKKa-Dependent Negative Feedback Control of Non-Canonical NF-kB Activation
非典型 NF-kB 激活的 IKKa 依赖性负反馈控制
  • 批准号:
    8039043
  • 财政年份:
    2011
  • 资助金额:
    $ 26.17万
  • 项目类别:
IKKa-Dependent Negative Feedback Control of Non-Canonical NF-kB Activation
非典型 NF-kB 激活的 IKKa 依赖性负反馈控制
  • 批准号:
    8208992
  • 财政年份:
    2011
  • 资助金额:
    $ 26.17万
  • 项目类别:
Mitiagrion of Radiation Damage by Mechanisms of Innate Immune Regulation
通过先天免疫调节机制减轻辐射损伤
  • 批准号:
    8011751
  • 财政年份:
    2010
  • 资助金额:
    $ 26.17万
  • 项目类别:
Role of IRF3 and RXRa Crosstalk in Host Response to Viral Infections
IRF3 和 RXRa 串扰在宿主对病毒感染的反应中的作用
  • 批准号:
    8091282
  • 财政年份:
    2009
  • 资助金额:
    $ 26.17万
  • 项目类别:
Role of IRF3 and RXRa Crosstalk in Host Response to Viral Infections
IRF3 和 RXRa 串扰在宿主对病毒感染的反应中的作用
  • 批准号:
    8481502
  • 财政年份:
    2009
  • 资助金额:
    $ 26.17万
  • 项目类别:

相似海外基金

ROLE OF CELL ADHESION IN BIOLOGICAL SIGNAL TRANSDUCTION
细胞粘附在生物信号转导中的作用
  • 批准号:
    6238317
  • 财政年份:
    1997
  • 资助金额:
    $ 26.17万
  • 项目类别:
CELL ADHESION IN BIOLOGICAL SIGNAL TRANSDUCTION
生物信号转导中的细胞粘附
  • 批准号:
    3732412
  • 财政年份:
  • 资助金额:
    $ 26.17万
  • 项目类别:
ROLE OF CELL ADHESION IN BIOLOGICAL SIGNAL TRANSDUCTION
细胞粘附在生物信号转导中的作用
  • 批准号:
    5210031
  • 财政年份:
  • 资助金额:
    $ 26.17万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了